Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01643954 · ClinicalTrials.gov registry record · NA

Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James

A NA study of Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
1,531
Enrollment target
1
Study location

NCT01643954: Active NA study of Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

NCT01643954 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,531 participants, above the 606-participant average among 735 other Prostate Cancer trials with a reported enrollment target (153% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01643954, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,531 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

Conditions Studied

Interventions

  • PROCEDURE robotic radical prostatectomy

Study Locations (1)

Ohio

  • Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 1,531 participants
Start Date 2008-09-23
Est. Completion 2027-07-31
Phase NA

What the registry record for NCT01643954 still lists

NCT01643954 is an interventional study that assigns participants to a tested intervention. Its 1,531 participants enrollment target places it among the larger protocols in the corpus, above the 606-participant average among 735 other Prostate Cancer trials with a reported enrollment target (153% higher).

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which robotic radical prostatectomy is the first listed.

NCT01643954 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01643954 about?

NCT01643954 is a clinical study titled "Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James". This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

What is the current status of trial NCT01643954?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,531 participants. The study started on 2008-09-23. Estimated completion is 2027-07-31.

What conditions does trial NCT01643954 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01643954?

The interventions under investigation include: robotic radical prostatectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01643954?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01643954 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01643954's enrollment target sits among peer trials

1,531 35th of 735 higher than 701 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06393374 · 1,530 participants · Phase 3

    Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • NCT07114510 · 1,530 participants · NA

    Optimal Ventilation for Cardiac Arrest

  • NCT06623097 · 1,528 participants · NA

    Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

  • NCT06842875 · 1,536 participants · NA

    Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01643954, the US trial registry maintained by the National Library of Medicine. NCT01643954 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.